Passage BIO PASG
NASDAQ PASG
$4.32 -0.18 (-4.11%)
As of: Oct 1, 2026 · 3:59 PM EDT

Passage BIO (PASG) Total Non-Current Liabilities (2019 - 2023)

Updated

Passage BIO's Total Non-Current Liabilities was $40.89 million in Q1 2023.

Analysis

Passage BIO (PASG) Total Non-Current Liabilities (2019 - 2023) Analysis & Trends

At the end of FY2021, Total Non-Current Liabilities at Passage BIO came in at $29.5 million, up 39.0% from FY2020.

  • In earlier years, Total Non-Current Liabilities was $21.22 million in FY2020 (-90.9%) and $234.36 million in FY2019.
  • The Q1 2023 figure marks the highest quarterly Total Non-Current Liabilities since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Passage BIO 14.48 Mn 14.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 40.89 Mn
Dec 31, 2021 29.50 Mn
Sep 30, 2021 22.25 Mn
Jun 30, 2021 31.25 Mn
Mar 31, 2021 19.47 Mn
Dec 31, 2020 21.22 Mn
Sep 30, 2020 19.15 Mn
Jun 30, 2020 14.18 Mn
Mar 31, 2020 5.27 Mn
Dec 31, 2019 234.36 Mn
API Access

Passage BIO Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PASG&period=max&api_key=YOUR_API_KEY